前列腺癌成像的新视野
New horizons in prostate cancer imaging.
作者信息
Ravizzini Gregory, Turkbey Baris, Kurdziel Karen, Choyke Peter L
机构信息
Molecular Imaging Program, National Cancer Institute, NIH, Bethesda, MD 20892-1088, USA.
出版信息
Eur J Radiol. 2009 May;70(2):212-26. doi: 10.1016/j.ejrad.2008.09.019. Epub 2008 Nov 7.
Abstract
Prostate cancer is the most common non-cutaneous malignancy among American men. Imaging has recently become more important in detection of prostate cancer since screening techniques such as digital rectal examination (DRE), prostate specific and transrectal ultrasound guided biopsy have considerable limitations in diagnosis and localization of prostate cancer. In this manuscript, we reviewed conventional, functional and targeted imaging modalities used in diagnosis and local staging of prostate cancer with exquisite images.
摘要
前列腺癌是美国男性中最常见的非皮肤恶性肿瘤。由于诸如直肠指检（DRE）、前列腺特异性抗原检测及经直肠超声引导下活检等筛查技术在前列腺癌的诊断和定位方面存在相当大的局限性，影像学检查最近在前列腺癌的检测中变得更加重要。在本手稿中，我们用精美的图像回顾了用于前列腺癌诊断和局部分期的传统、功能和靶向成像方式。
相似文献
1
New horizons in prostate cancer imaging.
Eur J Radiol. 2009 May;70(2):212-26. doi: 10.1016/j.ejrad.2008.09.019. Epub 2008 Nov 7.
2
[New ultrasound technologies for the diagnostics of prostate cancer].
Radiologe. 2011 Nov;51(11):938, 940-6. doi: 10.1007/s00117-011-2178-y.
3
Imaging localized prostate cancer: current approaches and new developments.
AJR Am J Roentgenol. 2009 Jun;192(6):1471-80. doi: 10.2214/AJR.09.2527.
4
New agents and techniques for imaging prostate cancer.
J Nucl Med. 2009 Sep;50(9):1387-90. doi: 10.2967/jnumed.109.061838. Epub 2009 Aug 18.
5
Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
J Urol. 2013 Oct;190(4):1380-6. doi: 10.1016/j.juro.2013.04.043. Epub 2013 Apr 19.
6
Prospects in radionuclide imaging of prostate cancer.
Prostate. 2012 Aug 1;72(11):1262-72. doi: 10.1002/pros.22462. Epub 2011 Nov 29.
7
Ultrasound elastography of the prostate: state of the art.
Diagn Interv Imaging. 2013 May;94(5):551-60. doi: 10.1016/j.diii.2013.01.017. Epub 2013 Apr 19.
8
[Imaging diagnostics of the prostate].
Urologe A. 2010 Aug;49(8):963-75. doi: 10.1007/s00120-010-2338-0.
9
[Ultrasound contrast agents and prostate cancer].
Radiologe. 2005 Jun;45(6):544-51. doi: 10.1007/s00117-005-1193-2.
10
Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities--a radiologist's perspective.
NMR Biomed. 2014 Jan;27(1):3-15. doi: 10.1002/nbm.3002. Epub 2013 Sep 3.
引用本文的文献
1
Positron Emission Tomography Radiotracers for Identification of Site of Recurrence in Prostate Cancer After Primary Treatment Failure.
Cancers (Basel). 2025 May 21;17(10):1723. doi: 10.3390/cancers17101723.
2
Multiparametric Magnetic Resonance Imaging in Evaluation of Clinically Significant Prostate Cancer.
Indian J Radiol Imaging. 2021 Jan;31(1):65-77. doi: 10.1055/s-0041-1730093. Epub 2021 May 23.
3
Modern imaging and image-guided treatments of the prostate gland: MR and ablation for cancer and prostatic artery embolization for benign prostatic hyperplasia.
BJR Open. 2019 Aug 14;1(1):20190019. doi: 10.1259/bjro.20190019. eCollection 2019.
4
Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial.
Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):206-13. doi: 10.1016/j.ijrobp.2016.04.023. Epub 2016 Apr 30.
5
Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview.
Int Sch Res Notices. 2014 Jul 15;2014:243080. doi: 10.1155/2014/243080. eCollection 2014.
6
Clinical significance of incidental FDG uptake in the prostate gland detected by PET/CT.
Int J Clin Exp Med. 2015 Jul 15;8(7):10577-85. eCollection 2015.
7
Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization.
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1247-56. doi: 10.1007/s00259-015-3026-5. Epub 2015 Mar 11.
8
Pretargeted immunoPET of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody in mice with PC3 xenografts.
Mol Imaging Biol. 2015 Feb;17(1):94-101. doi: 10.1007/s11307-014-0772-x.
9
Diagnostic role of fluorodeoxyglucose positron emission tomography-computed tomography in prostate cancer.
Oncol Lett. 2014 Jun;7(6):2013-2018. doi: 10.3892/ol.2014.1997. Epub 2014 Mar 24.
10
Transperineal ultrasound-guided 12-core prostate biopsy: an extended approach to diagnose transition zone prostate tumors.
PLoS One. 2014 Feb 25;9(2):e89171. doi: 10.1371/journal.pone.0089171. eCollection 2014.
本文引用的文献
1
Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapy.
J Nucl Med. 2008 Jul;49(7):1066-74. doi: 10.2967/jnumed.107.049502. Epub 2008 Jun 13.
2
Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study.
Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1766-74. doi: 10.1007/s00259-008-0788-z. Epub 2008 May 9.
3
11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
Eur Urol. 2008 Aug;54(2):392-401. doi: 10.1016/j.eururo.2008.04.030. Epub 2008 Apr 18.
4
Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer.
Mol Imaging. 2008 Jan-Feb;7(1):12-20.
5
Indium-111 capromab pendetide in the management of recurrent prostate cancer.
Expert Rev Anticancer Ther. 2008 Feb;8(2):175-81. doi: 10.1586/14737140.8.2.175.
6
Age-related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues.
J Magn Reson Imaging. 2008 Mar;27(3):552-6. doi: 10.1002/jmri.21117.
7
8
Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Invest Radiol. 2007 Dec;42(12):842-7. doi: 10.1097/RLI.0b013e3181461d21.
9
Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.
Nucl Med Biol. 2007 Oct;34(7):757-78. doi: 10.1016/j.nucmedbio.2007.04.001. Epub 2007 Jun 8.
10
Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.
Radiology. 2007 Nov;245(2):499-506. doi: 10.1148/radiol.2452062201. Epub 2007 Sep 21.
Zotero 插件